On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...